This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Perspective Therapeutics, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Andrew W Knight: Innovator in Lead Radioisotope Separation
Introduction
Andrew W Knight is a notable inventor based in Albuquerque, NM (US). He has made significant contributions to the field of radioisotope separation, particularly through his innovative patent. His work is essential for advancements in medical applications and radiopharmaceuticals.
Latest Patents
Andrew W Knight holds a patent for "Systems and methods for generating lead." This patent describes a method for separating a lead radioisotope from a mixture that includes both the lead radioisotope and radioisotopes of radium or thorium. The system comprises multiple chromatographic columns, including a first cartridge with lead-complexing media that preferentially binds the lead radioisotope. Additionally, it features a second cartridge with weak cationic exchange media, designed to optimize the separation process. The system aims to provide a purified solution of lead radioisotope for medical and other applications, such as labeling radiopharmaceutical compounds.
Career Highlights
Andrew W Knight is associated with Perspective Therapeutics, Inc., where he applies his expertise in radioisotope separation. His innovative approach has positioned him as a key figure in the development of technologies that enhance the efficiency of lead radioisotope extraction.
Collaborations
Andrew has collaborated with notable colleagues, including Edwin A Sagastume and Michael K Schultz. Their combined efforts contribute to the advancement of technologies in the field of radiopharmaceuticals.
Conclusion
Andrew W Knight's contributions to the field of radioisotope separation are invaluable. His innovative patent and work at Perspective Therapeutics, Inc. highlight his commitment to advancing medical applications. His efforts pave the way for future developments in the use of lead radioisotopes in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile